Customized IV Drips Near Incheon Airport Korea

Pharmacokinetics of Intravenous vs. Oral Delivery

The fundamental advantage of IV nutrient therapy lies in pharmacokinetics. Oral vitamin C absorption is limited by sodium-dependent vitamin C transporters (SVCT1 and SVCT2) in the intestinal epithelium, capping blood levels at approximately 220 micromol/L regardless of oral dose. IV administration bypasses this bottleneck entirely, achieving plasma concentrations of 13,000-15,000 micromol/L — over 50 times higher than oral maximum. At these pharmacological concentrations, vitamin C exhibits pro-oxidant effects in tumor microenvironments and powerful antioxidant effects systemically, creating therapeutic possibilities unavailable through oral supplementation. Similarly, oral glutathione is extensively degraded by gamma-glutamyl transferase in the intestinal lumen, with bioavailability estimated at only 3-5%. IV glutathione achieves immediate, full-dose systemic distribution.

Glutathione and Melanogenesis Inhibition

Glutathione (GSH) is the body’s master antioxidant and a key regulator of melanin synthesis. GSH inhibits melanogenesis through two mechanisms: (1) direct inhibition of tyrosinase, the rate-limiting enzyme in melanin production, and (2) shifting melanin synthesis from dark eumelanin to lighter pheomelanin by conjugating with dopaquinone. Watanabe et al. (2014) demonstrated in a randomized controlled trial that oral glutathione supplementation reduced melanin index scores in UV-exposed skin, with the effect more pronounced for GSH than placebo. At the supraphysiological concentrations achievable via IV delivery, this melanogenesis-inhibiting effect is amplified, explaining the skin brightening results observed clinically after IV glutathione courses. The combination of glutathione with vitamin C is synergistic — ascorbic acid recycles oxidized glutathione (GSSG) back to reduced GSH, maintaining the active form.

NAD+ and Cellular Aging

Nicotinamide adenine dinucleotide (NAD+) is essential for mitochondrial energy production, DNA repair via PARP enzymes, and sirtuin-mediated gene regulation. NAD+ levels decline approximately 50% between ages 40 and 60, contributing to cellular aging, reduced energy metabolism, and impaired DNA repair capacity. IV NAD+ infusion directly replenishes cellular NAD+ pools, activating sirtuins (SIRT1-7) that regulate inflammation, autophagy, and circadian rhythms. Rajman et al. (2018) reviewed the therapeutic potential of boosting NAD+ levels, concluding that NAD+ supplementation shows promise for age-related conditions. RE:BERRY’s anti-aging IV protocol combines NAD+ with supporting nutrients (niacin, tryptophan, quercetin) to maximize NAD+ bioavailability and retention.

Autologous Blood-Derived Growth Factors

The EVER YOUTH protocol represents the most advanced IV therapy available at RE:BERRY. Autologous blood is drawn and processed to isolate concentrated platelet-derived growth factors (PDGF), transforming growth factor-beta (TGF-beta), vascular endothelial growth factor (VEGF), and exosome-rich fractions. These are combined with the Eternal Booster ampoule containing additional regenerative compounds. When reinfused intravenously, these autologous factors circulate systemically, promoting tissue repair, collagen synthesis, and cellular regeneration throughout the body. Unlike synthetic growth factors, autologous preparations carry zero allergy or rejection risk. RE:BERRY’s stem cell treatment protocols build on this same autologous regenerative medicine foundation.

References: Padayatty SJ et al. Ann Intern Med. 2004;140(7):533-537. doi:10.7326/0003-4819-140-7-200404060-00010 | Watanabe F et al. Clin Cosmet Investig Dermatol. 2014;7:267-274. doi:10.2147/CCID.S68890 | Rajman L et al. Cell Metab. 2018;27(3):529-547. doi:10.1016/j.cmet.2018.02.011